Viatris Inc (VTRS)
11.58
+0.11
(+0.96%)
USD |
NASDAQ |
Apr 26, 11:34
Viatris Enterprise Value: 30.56B for April 25, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 25, 2024 | 30.56B |
| April 24, 2024 | 30.65B |
| April 23, 2024 | 30.43B |
| April 22, 2024 | 30.30B |
| April 19, 2024 | 30.30B |
| April 18, 2024 | 30.14B |
| April 17, 2024 | 30.12B |
| April 16, 2024 | 30.14B |
| April 15, 2024 | 30.38B |
| April 12, 2024 | 30.39B |
| April 11, 2024 | 30.68B |
| April 10, 2024 | 30.84B |
| April 09, 2024 | 30.98B |
| April 08, 2024 | 30.89B |
| April 05, 2024 | 30.95B |
| April 04, 2024 | 30.90B |
| April 03, 2024 | 31.21B |
| April 02, 2024 | 31.12B |
| April 01, 2024 | 31.12B |
| March 28, 2024 | 31.12B |
| March 27, 2024 | 30.99B |
| March 26, 2024 | 30.71B |
| March 25, 2024 | 30.99B |
| March 22, 2024 | 31.00B |
| March 21, 2024 | 31.20B |
| Date | Value |
|---|---|
| March 20, 2024 | 31.05B |
| March 19, 2024 | 31.03B |
| March 18, 2024 | 30.90B |
| March 15, 2024 | 31.12B |
| March 14, 2024 | 30.98B |
| March 13, 2024 | 31.25B |
| March 12, 2024 | 31.26B |
| March 11, 2024 | 31.15B |
| March 08, 2024 | 31.50B |
| March 07, 2024 | 31.58B |
| March 06, 2024 | 31.43B |
| March 05, 2024 | 31.52B |
| March 04, 2024 | 31.62B |
| March 01, 2024 | 31.89B |
| February 29, 2024 | 31.63B |
| February 28, 2024 | 31.53B |
| February 27, 2024 | 32.65B |
| February 26, 2024 | 32.89B |
| February 23, 2024 | 33.01B |
| February 22, 2024 | 32.80B |
| February 21, 2024 | 32.86B |
| February 20, 2024 | 32.84B |
| February 16, 2024 | 32.62B |
| February 15, 2024 | 32.33B |
| February 14, 2024 | 31.43B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
18.93B
Minimum
Mar 12 2020
47.41B
Maximum
Dec 31 2020
30.50B
Average
30.84B
Median
Feb 05 2024
Enterprise Value Benchmarks
| Johnson & Johnson | 360.21B |
| Pfizer Inc | 201.07B |
| Masimo Corp | 7.899B |
| Intuitive Surgical Inc | 127.63B |
| QuidelOrtho Corp | 4.901B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -765.60M |
| Revenue (Quarterly) | 3.837B |
| Total Expenses (Quarterly) | 4.049B |
| EPS Diluted (Quarterly) | -0.64 |
| Gross Profit Margin (Quarterly) | 41.60% |
| Profit Margin (Quarterly) | -19.95% |
| Earnings Yield | 0.35% |
| Operating Earnings Yield | 7.04% |
| Normalized Earnings Yield | 1.744 |